| Literature DB >> 8113524 |
L M Golub1, M Wolff, S Roberts, H M Lee, M Leung, G S Payonk.
Abstract
A new therapeutic approach involves the discovery by the "Stony Brook group," that tetracyclines, but not other antibiotics, can inhibit host-derived collagen-destructive enzymes. This newly discovered property of tetracyclines is unrelated to the antimicrobial activity of these drugs. Examples support the hypothesis that this unexpected property of tetracyclines provides a new approach to treating periodontal diseases as well as a variety of medical disorders.Entities:
Mesh:
Substances:
Year: 1994 PMID: 8113524 DOI: 10.14219/jada.archive.1994.0261
Source DB: PubMed Journal: J Am Dent Assoc ISSN: 0002-8177 Impact factor: 3.634